Chenlin Hu

993 total citations
33 papers, 731 citations indexed

About

Chenlin Hu is a scholar working on Infectious Diseases, Environmental Chemistry and Molecular Biology. According to data from OpenAlex, Chenlin Hu has authored 33 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Environmental Chemistry and 10 papers in Molecular Biology. Recurrent topics in Chenlin Hu's work include Aquatic Ecosystems and Phytoplankton Dynamics (13 papers), Clostridium difficile and Clostridium perfringens research (11 papers) and Marine and coastal ecosystems (9 papers). Chenlin Hu is often cited by papers focused on Aquatic Ecosystems and Phytoplankton Dynamics (13 papers), Clostridium difficile and Clostridium perfringens research (11 papers) and Marine and coastal ecosystems (9 papers). Chenlin Hu collaborates with scholars based in United States, China and Poland. Chenlin Hu's co-authors include Piotr Rzymski, Nanqin Gan, Lirong Song, Lin Zhu, Jin Liu, Yan Xiao, Nicholas D. Beyda, Zhongxing Wu, Samuel L Aitken and Elke Dittmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Water Research and Clinical Infectious Diseases.

In The Last Decade

Chenlin Hu

30 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenlin Hu United States 14 391 210 199 150 121 33 731
Sonja Nybom Finland 14 408 1.0× 250 1.2× 137 0.7× 134 0.9× 39 0.3× 16 728
Libertad Garcı́a-Villada Spain 13 262 0.7× 136 0.6× 82 0.4× 154 1.0× 16 0.1× 19 729
Thaiya Krishnamurthy United States 12 451 1.2× 239 1.1× 208 1.0× 276 1.8× 25 0.2× 27 1.1k
Xin Lin China 21 220 0.6× 428 2.0× 28 0.1× 504 3.4× 44 0.4× 57 1.3k
Vera Regina Werner Brazil 10 329 0.8× 174 0.8× 71 0.4× 134 0.9× 28 0.2× 29 650
Gurjeet S. Kohli Australia 25 556 1.4× 342 1.6× 27 0.1× 836 5.6× 31 0.3× 39 1.4k
Yanling Bai China 18 70 0.2× 59 0.3× 63 0.3× 414 2.8× 21 0.2× 47 792
Andrés González Spain 17 63 0.2× 49 0.2× 85 0.4× 326 2.2× 34 0.3× 33 597
Y. K. Lee Singapore 8 154 0.4× 141 0.7× 47 0.2× 290 1.9× 34 0.3× 10 903
Janet Crowley United States 9 172 0.4× 81 0.4× 40 0.2× 54 0.4× 45 0.4× 11 338

Countries citing papers authored by Chenlin Hu

Since Specialization
Citations

This map shows the geographic impact of Chenlin Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenlin Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenlin Hu more than expected).

Fields of papers citing papers by Chenlin Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenlin Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenlin Hu. The network helps show where Chenlin Hu may publish in the future.

Co-authorship network of co-authors of Chenlin Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Chenlin Hu. A scholar is included among the top collaborators of Chenlin Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenlin Hu. Chenlin Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Chenlin, Thomas D. Horvath, Sigmund J. Haidacher, et al.. (2025). Phase I trial comparing bile acid and short-chain fatty acid alterations in stool collected from human subjects treated with omadacycline or vancomycin. Antimicrobial Agents and Chemotherapy. 69(2). e0125124–e0125124. 1 indexed citations
2.
Hu, Chenlin & Hong Shen. (2024). Microbes in Health and Disease: Human Gut Microbiota. Applied Sciences. 14(23). 11354–11354. 4 indexed citations
3.
Wei, Nian, Chenlin Hu, Elke Dittmann, Lirong Song, & Nanqin Gan. (2024). The biological functions of microcystins. Water Research. 262. 122119–122119. 21 indexed citations
4.
Hu, Chenlin, et al.. (2024). Development and validation of LC-MS/MS for quantifying omadacycline from stool for gut microbiome studies. Journal of Chromatography B. 1236. 124057–124057. 3 indexed citations
5.
Eubank, Taryn A, Chenlin Hu, Anne J Gonzales-Luna, & Kevin W. Garey. (2023). Detectable Vancomycin Stool Concentrations in Hospitalized Patients with Diarrhea Given Intravenous Vancomycin. SHILAP Revista de lepidopterología. 2(4). 283–288. 3 indexed citations
6.
Hu, Chenlin, Khurshida Begum, Weiqun Wang, et al.. (2023). Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers. The Journal of Infectious Diseases. 229(1). 273–281. 6 indexed citations
7.
Lee, Jiyoung, Seungjun Lee, Chenlin Hu, & Jason W. Marion. (2023). Beyond cyanotoxins: increased Legionella, antibiotic resistance genes in western Lake Erie water and disinfection-byproducts in their finished water. Frontiers in Microbiology. 14. 1233327–1233327. 6 indexed citations
8.
Hu, Chenlin & Kevin W. Garey. (2023). Nonmammalian models to study Clostridioides difficile infection; a systematic review. Anaerobe. 79. 102694–102694. 1 indexed citations
9.
Mason, Clive, Tim Avis, Chenlin Hu, et al.. (2023). The Novel DNA Binding Mechanism of Ridinilazole, a Precision Clostridiodes difficile Antibiotic. Antimicrobial Agents and Chemotherapy. 67(5). e0156322–e0156322. 5 indexed citations
10.
Garey, Kevin W., An Q Dinh, Chenlin Hu, et al.. (2022). Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial. Clinical Infectious Diseases. 75(7). 1164–1170. 25 indexed citations
11.
Hu, Chenlin, et al.. (2022). Heterogeneity and lyophilization comparison of stool processing for gastrointestinal bile acid measurement by LC-MS/MS. Journal of Chromatography B. 1214. 123569–123569. 5 indexed citations
12.
Zarębska‐Michaluk, Dorota, et al.. (2022). COVID-19 Vaccine Booster Strategies for Omicron SARS-CoV-2 Variant: Effectiveness and Future Prospects. Vaccines. 10(8). 1223–1223. 13 indexed citations
13.
Hu, Chenlin, et al.. (2022). Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrata. Microbiology Spectrum. 10(1). e0183721–e0183721. 3 indexed citations
14.
Hu, Chenlin, et al.. (2019). Antifungal Resistance: a Concerning Trend for the Present and Future. Current Infectious Disease Reports. 21(12). 47–47. 98 indexed citations
15.
Hu, Chenlin, Stuart A. Ludsin, Jay F. Martin, Elke Dittmann, & Jiyoung Lee. (2018). Mycosporine-like amino acids (MAAs)—producing Microcystis in Lake Erie: Development of a qPCR assay and insight into its ecology. Harmful Algae. 77. 1–10. 15 indexed citations
16.
18.
Gan, Nanqin, Yan Xiao, Lin Zhu, et al.. (2011). The role of microcystins in maintaining colonies of bloom‐forming Microcystis spp.. Environmental Microbiology. 14(3). 730–742. 196 indexed citations
19.
Hu, Chenlin, Nanqin Gan, Yuanyuan Chen, et al.. (2009). Detection of microcystins in environmental samples using surface plasmon resonance biosensor. Talanta. 80(1). 407–410. 49 indexed citations
20.
Hu, Chenlin, Nanqin Gan, Zhike He, & Lirong Song. (2008). A novel chemiluminescent immunoassay for microcystin (MC) detection based on gold nanoparticles label and its application to MC analysis in aquatic environmental samples. International Journal of Environmental & Analytical Chemistry. 88(4). 267–277. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026